Compare Becton Dickinson and Co (BDX) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Novavax Inc — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $49.41B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Becton Dickinson and Co is far larger — about 37.7× Novavax Inc's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| BDX | NVAX | |
|---|---|---|
Market Cap | $49.41B | $1.31B |
Sector | Health | Health |
52-Week High | $185.39 | $11.19 |
52-Week Low | $138.62 | $6.22 |
Enterprise Value | $65.51B | $889.30M |
Dividend Yield | 2.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
